brain cell phones: Microwave News Article Archive (2004 - )

The incidence of glioblastoma multiforme, GBM, the most aggressive type of brain tumor, though rising slowly over the last 20 years, has not jumped up in the U.S. and Canada, as it has in England and a number of other northern European countries, according to a new analysis of national brain tumor registry data.

Between 1995 and 2015, GBM rates went up 10% in the U.S. and 26% in Canada. In contrast, the increase in England over the same period was 110%.

De-Kun Li wants to change the conversation on cell phones and cancer. Li, a senior epidemiologist and veteran EMF researcher, believes that brain tumors have been getting too much attention at the expense of other types of cancer, notably colorectal cancer.

Efforts to reduce colon and rectal cancers have been a striking success story for those over 50 years old. Incidence among older Americans declined 32% between 2000 and 2013, due largely to better screening. But the story for young adults is very different. Those born around 1990 now face four times the risk of developing rectal cancer and twice the risk of colon cancer in their 20s, compared to those born around 1950, according to the American Cancer Society.

“No one can explain this apparent contradiction,” Li told Microwave News. Known risk factors for colorectal cancer include obesity, an unhealthy diet and lack of physical activity, but Li doesn’t think they can resolve the paradox.

“We believe that the link between radiofrequency (RF) radiation and tumors in male rats is real,” says John Bucher, the former associate director of the U.S. National Toxicology Program (NTP).

The announcement accompanies this morning’s release of the NTP final reports of studies on cancer in rats and mice exposed to cell phone radiation. Bucher’s project, the largest in NTP history, cost $30 million and took more than ten years to complete.

The NTP found what it calls “clear evidence” that two different types of cell phone signals, GSM and CDMA, increased the incidence of malignant tumors in the hearts of male rats over the course of the two-year study.

Japanese and Korean officials are working on a partial replication of the U.S. National Toxicology Program (NTP) animal study on cancer risks from cell phone radiation. The project is expected to be approved and get underway late next year.

Though collaborating on a common experimental design, each country will carry out its own exposures with animals from the same breeder. If the designs are similar enough, the two sets of data will be combined in a joint analysis.

“We have been discussing this issue in Japan,” said Masao Taki of the Department of Electrical and Electronic Engineering at Tokyo Metropolitan University, who was a member of ICNIRP from 1996 to 2008.

“You had it right the first time.” That was the implicit message to the National Toxicology Program (NTP) from an expert panel after a point-by-point review of NTP’s draft reports on its $25 million study of cancer risks of cell phone radiation in mice and rats.

Two years ago, with the results in hand, the NTP rushed to warn the public about the dangers of cell phones. It issued an interim report pointing to higher rates of tumors in the hearts and brains of male rats exposed to two different kinds of phone radiation. Then early this February with the release of the formal draft reports, the NTP made a U-turn, saying that using a cell phone “is not a high-risk situation.”

Now a peer review panel —11 pathologists and toxicologists from academia and industry and one statistician— has concluded that there is “clear evidence of carcinogenic activity” in those male rats.

Why was the NTP so ambivalent about its cell phone cancer findings at the press conference last Friday when two years ago the same scientific evidence prompted a public health warning?

Some of the pathology numbers got tweaked since they were first released in 2016, but the changes were minor. It’s the same data set —but with a very different interpretation. The NTP mindset somehow shifted from we need to release this important new health data now to this is “not a high-risk situation.”

Who or what moved the NTP managers to change their outlook? There’s no shortage of suspects and suspicions.